/wp-content/uploads/candel_logo.svg
0
0
cchan@candeltx.com
/wp-content/uploads/candel_logo.svg
cchan@candeltx.com2021-04-13 05:04:502021-04-13 08:29:03Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
/wp-content/uploads/candel_logo.svg
0
0
cchan@candeltx.com
/wp-content/uploads/candel_logo.svg
cchan@candeltx.com2021-04-09 05:02:342021-04-09 05:02:34Candel Therapeutics Appoints Chris Matheny, PharmD, Ph.D., as Vice President, Development Leader
/wp-content/uploads/candel_logo.svg
0
0
David Anderson
/wp-content/uploads/candel_logo.svg
David Anderson2020-12-08 08:00:532020-12-08 08:00:53Candel Therapeutics Appoints Pharma Veteran and Immunologist Paul-Peter Tak, M.D., Ph.D., as Chief Executive Officer; Expands Leadership Team With Chief Financial Officer, Chief Business Officer and Chief Regulatory Officer Appointments
/wp-content/uploads/candel_logo.svg
0
0
David Anderson
/wp-content/uploads/candel_logo.svg
David Anderson2020-05-30 08:00:392020-05-30 08:00:39Candel Therapeutics Announces Presentation of Clinical Data for GMCI in NSCLC at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
/wp-content/uploads/candel_logo.svg
0
0
David Anderson
/wp-content/uploads/candel_logo.svg
David Anderson2020-05-18 08:00:012020-05-18 08:00:01Candel Therapeutics Announces Presentation at the 2020 American Society of Gene and Cell Therapy (ASGCT) 23rd Annual Meeting
/wp-content/uploads/candel_logo.svg
0
0
David Anderson
/wp-content/uploads/candel_logo.svg
David Anderson2020-01-08 08:00:542020-01-08 08:00:54Candel Therapeutics acquires next-generation herpes drug development platform and manufacturing expertise
